Delivery Order SPE2DB22D9367-SPE2DB24FSZ96

Award Date 9/25/24
Potential Completion Date 10/17/24
Potential Value $53K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device, to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $3,552.00 and an ultimate completion date of September 5, 2024....
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $1,726.89 and is a firm fixed-price delivery order with no set-aside designation. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This award is part of a larger indefinite delivery contract (IDC) held by DMS...
This federal contract award is for the delivery of Mirena contraceptive systems to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $14,121.50 and a completion date of April 18, 2022. It is issued under DMS Pharmaceutical Group's...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $8,880.00 and a period of performance through September 19, 2024. It is issued under a larger $499,999,999...
This federal contract award is for the delivery of Mirena 52 mg systems, a type of intrauterine device (IUD), to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order with a firm fixed price of $5,920.00 and a ceiling value of $5,920.00. It has an ultimate completion date of November 12,...
This federal contract award is for the delivery of Mirena 52 mg systems, a type of long-acting reversible contraceptive, to the Defense Logistics Agency (DLA). The $23,088 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This federal contract award is for the delivery of 4,565,404,982 units of the Mirena 52 mg intrauterine system to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $4,736.00, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $59,200.00 and an ultimate completion date of October 18, 2024. DMS Pharmaceutical Group Inc. specializes in providing a wide range of pharmaceutical...
This federal contract award is for the delivery of Mirena 52 mg Systems, a type of intrauterine device, to the Defense Logistics Agency (DLA). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed-price delivery order type, with a ceiling value of $4,736.00 and an ultimate completion date of December 26, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award...
This federal contract award is for the delivery of Mirena 52 mg systems, a type of intrauterine device (IUD), to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract has a ceiling value of $8,714.40 and an ultimate completion date of August 28, 2023. It is a firm fixed-price delivery order contract type awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSZ96
    Delivery Order

This federal contract award is for the delivery of Mirena 52 mg intrauterine systems to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois.

The contract is a firm fixed-price delivery order with a ceiling value of $53,280.00 and an ultimate completion date of October 17, 2024. It is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds this single-award IDC, solidifying its position as a crucial supplier in the federal pharmaceutical supply chain.

Generated 12/25/24, 9:15 AM